（文章来源：证券日报） 证券日报网讯 1月15日，珀莱雅发布公告称，2026年1月15日，公司通过集中竞价交易方式首次回购公 司股份230，800股，占公司目前总股本的比例为0.06%。 ...

Market Overview - The cosmetics sector experienced a decline of 0.36% on January 15, with Shuiyang Co. leading the drop [1] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Individual Stock Performance - Jinsheng New Material (300849) saw a significant increase of 13.17%, closing at 18.48 with a trading volume of 117,000 shares and a turnover of 209 million yuan [1] - Qingdao Kingway (002094) increased by 2.06%, closing at 8.42 with a trading volume of 1,113,500 shares [1] - Lafang Home (603630) rose by 1.76%, closing at 24.27 with a trading volume of 137,300 shares [1] - Other notable performances include Fulejia (301371) up 0.73%, Marubi Biological (603983) up 0.70%, and Betaini (300957) up 0.32% [1] Capital Flow Analysis - The cosmetics sector saw a net outflow of 11.86 million yuan from institutional investors and 53.27 million yuan from retail investors, while retail investors had a net inflow of 65.13 million yuan [2] - The capital flow for individual stocks indicates that Lafang Home had a net inflow of 77.73 million yuan from institutional investors, while Betaini had a net inflow of 14.81 million yuan [3] - Conversely, Shuiyang Co. experienced a net outflow of 5.39 million yuan from institutional investors [2][3]

关于以集中竞价交易方式首次回购股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2026-004 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司 一、 回购股份的基本情况 公司于 2025 年 12 月 30 日召开第四届董事会第十一次会议，审议通过了《关 于以集中竞价交易方式回购股份方案的议案》，同意公司以自有资金通过集中竞价 交易方式进行股份回购，并在未来适宜时机用于股权激励或员工持股计划。本次 回购资金总额不低于人民币 8,000 万元（含本数）,不超过人民币 15,000 万元（含 本数），回购的价格不超过人民币 100 元/股（含），不高于董事会通过回购决议前 30 个交易日公司股票交易均价的 150%，回购期限为自公司董事会审议通过本次回 购股份方案之日起 12 个月内。具体内容详见公司于 2025 年 12 月 31 日在上海证 券交易所网站（www.sse. ...

21智讯1月15日电，珀莱雅公告，2026年1月15日，公司通过集中竞价交易方式首次回购公司股份23.08 万股，占公司目前总股本的比例为0.06%，回购成交的最高价为69.95元/股，最低价为69.76元/股，支付 的资金总额为1,611.9331万元（不含印花税、佣金等交易费用）。本次回购股份符合法律法规的规定及 公司的回购股份方案。公司将严格按照相关规定，在回购期限内根据市场情况择机做出回购决策并予以 实施，同时根据回购股份事项进展情况及时履行信息披露义务，敬请广大投资者注意投资风险。 ...

格隆汇1月15日丨珀莱雅(603605.SH)公布，2026年1月15日，公司通过集中竞价交易方式首次回购公司 股份23.08万股，占公司目前总股本的比例为0.06%，回购成交的最高价为69.95元/股，最低价为69.76元/ 股，支付的资金总额为人民币16,119,331.00元（不含印花税、佣金等交易费用)。 ...

珀莱雅公告称，公司于2025年12月30日决定以自有资金回购股份，用于股权激励或员工持股计划，回购 金额为8000万元-15000万元，回购期限至2026年12月29日。2026年1月15日，公司首次以集中竞价方式 回购股份23.08万股，占总股本0.06%，回购价格69.76元/股-69.95元/股，支付资金1611.9331万元。 ...

Investment Rating - The report indicates a positive investment outlook for the facial skincare industry, particularly in the e-commerce segment, with a projected growth rate of 19.4% year-on-year [9]. Core Insights - The facial skincare category is leading the beauty and skincare market, with significant sales growth on e-commerce platforms, especially on Douyin, which is expected to surpass 1340.39 billion in sales by 2024 [9][10]. - Tmall's market share is declining, projected to drop to 30.5% by 2024, while Douyin is rapidly gaining market share [9][10]. - The report highlights various product categories within facial skincare, noting that while some categories are experiencing growth, others are facing declines [12][14][16]. E-commerce Market Trends - The overall e-commerce market for facial skincare is expected to grow by 19.4% year-on-year, with Douyin becoming the leading platform [9]. - Tmall's sales are projected to decline, while Douyin's sales are expected to grow significantly, reaching 1340.39 billion by 2024 [9][10]. - The report provides detailed sales figures for major platforms, indicating a shift in consumer preferences towards Douyin [10]. Product Category Performance - The report categorizes facial skincare products into several key segments, including serums, creams, masks, and cleansers, with varying growth rates across these categories [8][12][14][16]. - Specific product categories such as lotions and toners are showing positive growth, while others like facial scrubs and certain masks are declining [12][14][16]. - Douyin shows remarkable growth in categories like facial care sets and liquid serums, with growth rates of 48.6% and 54.0% respectively [16][17]. Brand Performance - The report lists top-performing brands in the facial skincare market, highlighting significant sales figures and growth rates for brands like Proya, L'Oreal, and Estee Lauder [19][20][21]. - Proya is noted for its strong growth, with a sales increase of 103.9%, while other brands like Sk-II and Olay are experiencing declines [19][20][21]. - The competitive landscape is shifting, with emerging brands gaining traction alongside established players [19][20][21].

Core Viewpoint - The stock price of Proya has shown a positive trend with a year-to-date increase of 4.67%, and a significant rise of 7.50% over the past 20 days, despite a decline of 7.75% over the last 60 days [2]. Group 1: Stock Performance - As of January 14, Proya's stock price increased by 2.01%, reaching 71.68 CNY per share, with a trading volume of 1.97 billion CNY and a turnover rate of 0.70% [1]. - The net inflow of main funds was 6.37 million CNY, with large orders accounting for 28.01% of purchases and 24.89% of sales [1]. Group 2: Financial Performance - For the period from January to September 2025, Proya achieved a revenue of 7.098 billion CNY, reflecting a year-on-year growth of 1.89%, and a net profit attributable to shareholders of 1.026 billion CNY, up by 2.65% [2]. - Since its A-share listing, Proya has distributed a total of 2.125 billion CNY in dividends, with 1.540 billion CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, Proya had 84,100 shareholders, an increase of 39.53% from the previous period, with an average of 4,708 circulating shares per shareholder, down by 28.23% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 27.11 million shares, a decrease of 20.41 million shares from the previous period [3].

Summary of China Cosmetics Sector Conference Call Industry Overview - The China cosmetics sector is expected to experience a reset for higher-quality growth in 2026, moving away from reliance on high-cost Key Opinion Leaders (KOLs) and focusing on popular core SKUs. This shift has led to a contraction in Net Profit Margin (NPM) due to deleveraging impacts, despite improvements in Return on Investment (ROI) [1][2]. Key Trends and Insights - **Consumer Acquisition Costs**: Monitoring new consumer acquisition costs will be critical, especially as channel migration benefits diminish and the ingredient cycle remains ambiguous. Anti-involution policies will also play a significant role [1]. - **Branding Strategy**: Branding is anticipated to be the most effective strategy for consumer engagement and new product launches in 2026. Companies with high repurchase rates and cost-efficient omni-channel strategies are better positioned for success [1][2]. - **Market Dynamics**: The cosmetics market is expected to grow at a normalized rate, with growth projected at less than 1x GDP growth. The market is forecasted to see a 2.1% increase in beauty spending in 2026, with a mix of onshore and offshore market performance [17][18]. Company-Specific Insights - **Mao Geping Cosmetics (MGP)**: Upgraded from Neutral to Buy with a target price increase from HK$89 to HK$105, reflecting a 27% upside. The company is noted for strong branding and a balanced channel presence, with a forecasted sales and net income CAGR of 23% and 22% from 2025 to 2027, respectively [2][9]. - **Giant Biogene**: Maintained as Buy, with a target price lowered from HK$71 to HK$46, indicating a 36% upside. The company is expected to recover with new skincare products and a focus on medical aesthetics, projecting sequential growth of -8%/+12%/+17% YoY for 1H26E/2H26E/2027E [2][9]. - **Shanghai Jahwa**: Target price reduced from RMB 31 to RMB 28, with a 22% upside. The company is on a turnaround trajectory with improving margins and cash flow [2][9]. - **Proya Cosmetics**: Remains Neutral as the company is expected to moderate organic growth while awaiting more execution on white space exploration [2][9]. - **Botanee Biotech**: Neutral rating with early signs of a potential turnaround but lacking clear growth drivers [2][9]. - **Bloomage Biotech**: Maintained as Sell due to downside risks in skincare and muted growth in medical aesthetics amid a mature product cycle [2][9]. Market Performance and Projections - **E-commerce Trends**: Tmall is expected to maintain strong growth momentum, supported by anti-involution measures. Douyin's performance has been softer than expected, with a significant decline in KOL channel performance [19][21]. - **Sales Growth Expectations**: The cosmetics sector is projected to see sustained GMV growth on Tmall, while Douyin is expected to experience a narrowing gap in growth rates compared to Tmall [20][21]. Conclusion - The China cosmetics sector is poised for a shift towards higher-quality growth in 2026, with branding and strategic channel management becoming increasingly important. Companies that adapt to these changes and focus on core products are likely to outperform in the evolving market landscape [1][2][19].

Investment Rating - The report maintains an "Outperform" rating for the retail sector [3][56]. Core Insights - The retail sector is expected to benefit from increased policy support, with leading companies poised for growth [1][3]. - The overall consumption environment in 2025 is projected to be stable, with structural highlights emerging, particularly as consumption policies become clearer [1][12]. - The report identifies two main trends for 2026: the continuation of new consumption trends and the anticipated reversal of challenges faced by traditional consumption [2][20]. Summary by Sections Market Performance Review - In 2025, the SW retail index increased by 11.6%, underperforming the CSI 300 index by 6.1 percentage points, while the beauty care index rose by only 0.4%, lagging behind the CSI 300 by 17.35 percentage points [1][16]. - The retail sector's performance was initially strong in the first half of 2025 but faced a decline in the second half due to a shift in market focus towards technology [1][16]. Investment Recommendations - The report suggests several sectors for investment: 1. **Gold and Jewelry**: The sector is entering a consumption peak, with low valuations and expected growth in same-store sales and channel expansion. Recommended companies include潮宏基, 菜百股份, and 周大福 [3][56]. 2. **Beauty and Personal Care**: The sector is returning to low valuations, with traditional leaders showing signs of recovery. Recommended companies include 上美股份 and 珀莱雅 [3][56]. 3. **Offline Retail**: The end of the year is a peak sales period, with potential positive impacts from CPI recovery. Recommended companies include 名创优品 and 永辉超市 [3][56]. 4. **Cross-border E-commerce**: Companies are expected to benefit from reduced external tariff impacts, with recommendations including 小商品城 and 安克创新 [3][56]. Key Company Earnings Forecasts - The report provides earnings forecasts and investment ratings for key companies, all rated "Outperform" for 2025 and 2026, including 潮宏基, 上美股份, and 珀莱雅, with respective PE ratios indicating growth potential [5][59]. Recent Industry Data Tracking - As of November 2025, the total retail sales of consumer goods reached 43,898 billion yuan, with a year-on-year growth of 1.3%. The growth was influenced by high base effects and the timing of promotional events [26][30]. - Online retail sales for the first 11 months of 2025 reached 144,582 billion yuan, growing by 9.1%, with physical goods online retail accounting for 25.9% of total retail sales [28][30]. Policy Support and Future Outlook - Recent policy initiatives emphasize the importance of boosting consumer spending, with a focus on increasing the consumption rate and stabilizing demand through various measures [13][24]. - The report anticipates that traditional consumption leaders will gradually improve their performance as they adapt to new market conditions and innovate their product offerings [24][20].